Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you – page 568

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Amyotrophic lateral sclerosis

Not recruiting

Study on the Effects of Triumeq (Abacavir Sulfate, Lamivudine, Dolutegravir Sodium) in Patients with Amyotrophic Lateral Sclerosis (ALS)

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abacavir Sulfate

Rectal cancer

Not recruiting

Study on Valproic Acid with Bevacizumab and Oxaliplatin/Fluoropyrimidine for Patients with RAS-Mutated Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Valproic Acid

Hepatocellular carcinoma

Not recruiting

Study on Fecal Microbiota Transplant with Atezolizumab and Bevacizumab for Liver Cancer Patients Unresponsive to Previous Immunotherapy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Asthma

Not recruiting

Study on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Safety Study of Tasimelteon for Treating Non-24-Hour Sleep-Wake Disorder in Blind Individuals Without Light Perception

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Chronic obstructive pulmonary disease

Not recruiting

Study on Atorvastatin for Reducing COPD Exacerbations in Smokers with Chronic Obstructive Pulmonary Disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Chronic lymphocytic leukaemia+1

Not recruiting

Study of TL-895 and Navtemadlin for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone

Title: Evaluation of 68Ga-PSMA-11 PET/MRI and PET/CT Imaging for Treatment Planning in Patients with Intermediate and High-Risk Prostate Cancer

Not recruiting
InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

Medullary thyroid cancer

Not recruiting

Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years

Post-acute COVID-19 syndrome

Not recruiting

Study of Plitidepsin Treatment for Adults with Post-COVID-19 Condition

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Oesophageal carcinoma

Not recruiting

Study of trastuzumab with chemotherapy and immunotherapy combination for first-line treatment in patients with HER2-positive esophageal squamous cell cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Glomerulonephritis

Not recruiting

Study of Desmopressin for Prevention of Bleeding After Kidney Biopsy in Patients with Rare Glomerulonephritis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Desmopressin acetate

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.